Global markets entered the week facing a sharp contrast between the continuing expansion of the AI investment cycle and renewed pressure from energy and geopolitical risks. NVIDIA’s latest financing initiative points to a potentially important evolution in how AI infrastructure is funded, while higher oil prices, depleted U.S. emergency reserves and shifting healthcare policy highlight the risks that could challenge the broader risk-on environment.

NVIDIA Pushes AI Infrastructure Toward a New Financing Model

NVIDIA announced partnerships with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR aimed at mobilizing more than $500 billion of third-party capital for AI infrastructure over time. The company describes its computing infrastructure as an investable asset class, arguing that AI factories can generate long-duration revenue through a combination of hardware, software and continuing demand for computing capacity.

The development is significant because it potentially broadens AI financing beyond corporate capital expenditure. However, the scale of the headline number should be interpreted carefully. The $500 billion represents capital that the platforms are intended to mobilize over time, rather than NVIDIA receiving $500 billion in funding or revenue. The distinction is important for institutional investors assessing the sustainability of the AI capital cycle.

Oil Supply Risks Re-enter the Macro Narrative

Energy markets are presenting a more immediate macroeconomic challenge. The U.S. Strategic Petroleum Reserve fell by about 6.1 million barrels to 298.7 million barrels, its lowest level since January 1983. The decline comes after extensive releases intended to cushion the market from disruptions linked to the Iran conflict.

At the same time, Brent crude gained about 5% on Monday to $87.72, while WTI climbed 5.05% to $82.13 as uncertainty surrounding the reopening of the Strait of Hormuz intensified. Rising energy costs matter beyond commodities: they can feed into inflation expectations, corporate margins and monetary-policy expectations.

Policy Risk Broadens Beyond Markets

Healthcare policy has also become a market-relevant consideration. Trump signed an executive order on Monday seeking major changes to childhood vaccination recommendations, including separating the MMR vaccine into individual shots and reducing the number of diseases covered by routine recommendations. The order is guidance to federal agencies rather than legislation, while implementation remains subject to regulatory and legal processes.

For investors, the broader implication is policy uncertainty. Pharmaceutical companies, healthcare providers and insurers may face changing demand patterns, regulatory requirements and political scrutiny. The potential market impact is therefore likely to be company- and sector-specific rather than a straightforward directional trade.

Outlook: The remainder of the week will be particularly important for assessing whether markets can absorb the competing forces of AI investment optimism and renewed inflationary pressure. Wednesday’s U.S. inflation report could influence expectations for Federal Reserve policy, while developments surrounding the Strait of Hormuz remain critical for oil prices. For investors in Israel and globally, the key question is increasingly whether strong corporate fundamentals and AI-related capital formation can continue to outweigh geopolitical premiums, energy-price volatility, fiscal pressures and policy uncertainty. A constructive market environment remains possible, but the probability of sharper cross-asset volatility would rise if oil prices remain elevated or diplomatic efforts deteriorate.